2019冠状病毒病(COVID-19)相关急性呼吸窘迫综合征(CARDS)非abo相同恢复期血浆输注成功一例

R. Bhurayanontachai, Pisud Siripaitoon, Narongdet Kositpantawong, S. Chusri
{"title":"2019冠状病毒病(COVID-19)相关急性呼吸窘迫综合征(CARDS)非abo相同恢复期血浆输注成功一例","authors":"R. Bhurayanontachai, Pisud Siripaitoon, Narongdet Kositpantawong, S. Chusri","doi":"10.54205/ccc.v30.254752","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is pandemic with substantial fatality without specific treatment. Convalescent plasma is used to treat infectious diseases including severe acute respiratory syndrome coronavirus 1 and Middle East respiratory syndrome coronavirus infection, because of the effect of direct neutralizing and suppression of viremia, and immunomodulation effect. Although several anti-cytokine agents were suggested to improve outcomes of the patient, the unavailability of drugs will be a major problem for accessing. We reported the experience of convalescent plasma transfusion for COVID-19 related acute respiratory distress syndrome (CARDS), who refractory to standard treatment and clinically improvement after convalescent plasma transfusion, despite unidentical blood group.","PeriodicalId":76963,"journal":{"name":"AACN clinical issues in critical care nursing","volume":"71 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The success of non-ABO-identical convalescent plasma transfusion in coronavirus disease 2019 (COVID-19) related acute respiratory distress syndrome (CARDS): a case-report\",\"authors\":\"R. Bhurayanontachai, Pisud Siripaitoon, Narongdet Kositpantawong, S. Chusri\",\"doi\":\"10.54205/ccc.v30.254752\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Coronavirus disease 2019 (COVID-19) is pandemic with substantial fatality without specific treatment. Convalescent plasma is used to treat infectious diseases including severe acute respiratory syndrome coronavirus 1 and Middle East respiratory syndrome coronavirus infection, because of the effect of direct neutralizing and suppression of viremia, and immunomodulation effect. Although several anti-cytokine agents were suggested to improve outcomes of the patient, the unavailability of drugs will be a major problem for accessing. We reported the experience of convalescent plasma transfusion for COVID-19 related acute respiratory distress syndrome (CARDS), who refractory to standard treatment and clinically improvement after convalescent plasma transfusion, despite unidentical blood group.\",\"PeriodicalId\":76963,\"journal\":{\"name\":\"AACN clinical issues in critical care nursing\",\"volume\":\"71 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AACN clinical issues in critical care nursing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.54205/ccc.v30.254752\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AACN clinical issues in critical care nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54205/ccc.v30.254752","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

2019冠状病毒病(COVID-19)是一种大流行疾病,没有特异性治疗,死亡率很高。恢复期血浆由于具有直接中和抑制病毒血症和免疫调节作用,被用于治疗包括严重急性呼吸综合征冠状病毒1型和中东呼吸综合征冠状病毒感染在内的传染病。虽然一些抗细胞因子药物被建议改善患者的预后,但药物的不可获得性将是获得药物的主要问题。我们报道了恢复期血浆输注治疗COVID-19相关急性呼吸窘迫综合征(CARDS)的经验,恢复期血浆输注后,尽管血型不同,但标准治疗难治,临床好转。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The success of non-ABO-identical convalescent plasma transfusion in coronavirus disease 2019 (COVID-19) related acute respiratory distress syndrome (CARDS): a case-report
Coronavirus disease 2019 (COVID-19) is pandemic with substantial fatality without specific treatment. Convalescent plasma is used to treat infectious diseases including severe acute respiratory syndrome coronavirus 1 and Middle East respiratory syndrome coronavirus infection, because of the effect of direct neutralizing and suppression of viremia, and immunomodulation effect. Although several anti-cytokine agents were suggested to improve outcomes of the patient, the unavailability of drugs will be a major problem for accessing. We reported the experience of convalescent plasma transfusion for COVID-19 related acute respiratory distress syndrome (CARDS), who refractory to standard treatment and clinically improvement after convalescent plasma transfusion, despite unidentical blood group.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信